Enhabit (EHAB) Competitors $8.28 -0.24 (-2.82%) (As of 12/17/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends EHAB vs. AHCO, CDNA, PNTG, AVAH, AGL, CSTL, GRAL, INNV, FLGT, and AUNAShould you be buying Enhabit stock or one of its competitors? The main competitors of Enhabit include AdaptHealth (AHCO), CareDx (CDNA), The Pennant Group (PNTG), Aveanna Healthcare (AVAH), agilon health (AGL), Castle Biosciences (CSTL), Grail (GRAL), InnovAge (INNV), Fulgent Genetics (FLGT), and Auna (AUNA). These companies are all part of the "healthcare" industry. Enhabit vs. AdaptHealth CareDx The Pennant Group Aveanna Healthcare agilon health Castle Biosciences Grail InnovAge Fulgent Genetics Auna Enhabit (NYSE:EHAB) and AdaptHealth (NASDAQ:AHCO) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, media sentiment, profitability, community ranking, dividends, valuation, institutional ownership and earnings. Do institutionals and insiders believe in EHAB or AHCO? 82.7% of AdaptHealth shares are held by institutional investors. 1.9% of Enhabit shares are held by insiders. Comparatively, 4.4% of AdaptHealth shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media refer more to EHAB or AHCO? In the previous week, Enhabit had 4 more articles in the media than AdaptHealth. MarketBeat recorded 9 mentions for Enhabit and 5 mentions for AdaptHealth. AdaptHealth's average media sentiment score of 1.34 beat Enhabit's score of 1.16 indicating that AdaptHealth is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Enhabit 4 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AdaptHealth 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, EHAB or AHCO? Enhabit has a beta of 1.89, meaning that its share price is 89% more volatile than the S&P 500. Comparatively, AdaptHealth has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500. Does the MarketBeat Community favor EHAB or AHCO? AdaptHealth received 79 more outperform votes than Enhabit when rated by MarketBeat users. Likewise, 61.03% of users gave AdaptHealth an outperform vote while only 14.29% of users gave Enhabit an outperform vote. CompanyUnderperformOutperformEnhabitOutperform Votes414.29%Underperform Votes2485.71% AdaptHealthOutperform Votes8361.03% Underperform Votes5338.97% Which has higher valuation and earnings, EHAB or AHCO? Enhabit has higher earnings, but lower revenue than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than Enhabit, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnhabit$1.04B0.40-$80.50M-$2.32-3.57AdaptHealth$3.26B0.41-$678.90M-$1.65-6.08 Do analysts rate EHAB or AHCO? Enhabit presently has a consensus target price of $8.75, indicating a potential upside of 5.68%. AdaptHealth has a consensus target price of $11.67, indicating a potential upside of 16.20%. Given AdaptHealth's stronger consensus rating and higher probable upside, analysts plainly believe AdaptHealth is more favorable than Enhabit.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Enhabit 1 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00AdaptHealth 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83 Is EHAB or AHCO more profitable? AdaptHealth has a net margin of -6.57% compared to Enhabit's net margin of -11.24%. AdaptHealth's return on equity of 9.62% beat Enhabit's return on equity.Company Net Margins Return on Equity Return on Assets Enhabit-11.24% 1.67% 0.80% AdaptHealth -6.57%9.62%3.18% SummaryAdaptHealth beats Enhabit on 14 of the 18 factors compared between the two stocks. Ad Porter & CompanyForbes rich list released… #1 to be assassinated?Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.To get the full details on the fake “energy crisis” of America, watch this now Get Enhabit News Delivered to You Automatically Sign up to receive the latest news and ratings for EHAB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EHAB vs. The Competition Export to ExcelMetricEnhabitHome health care services IndustryMedical SectorNYSE ExchangeMarket Cap$416.35M$2.87B$5.18B$19.64BDividend YieldN/A0.36%4.78%3.51%P/E Ratio-3.5727.50127.8843.82Price / Sales0.401.131,262.6517.47Price / Cash3.2916.4941.1021.73Price / Book0.603.214.895.46Net Income-$80.50M-$57.02M$119.61M$987.68M7 Day Performance-3.61%-0.88%14.55%-2.12%1 Month Performance12.65%0.18%17.43%1.31%1 Year Performance-21.29%15.14%35.33%16.45% Enhabit Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EHABEnhabit2.1795 of 5 stars$8.28-2.8%$8.75+5.7%-21.3%$416.35M$1.04B-3.5710,800Positive NewsAHCOAdaptHealth3.0891 of 5 stars$9.99+4.6%$11.67+16.8%+29.7%$1.34B$3.26B-5.7910,700CDNACareDx3.7729 of 5 stars$22.52-1.5%$29.60+31.4%+122.1%$1.21B$280.32M-8.35740Short Interest ↑PNTGThe Pennant Group4.3264 of 5 stars$29.66+1.9%$38.25+29.0%+116.4%$1.02B$544.89M42.815,791Positive NewsAVAHAveanna Healthcare0.9029 of 5 stars$4.98-1.0%$4.27-14.3%+101.7%$962.26M$1.98B-14.7933,500Short Interest ↑AGLagilon health2.4276 of 5 stars$2.23-0.4%$4.28+92.1%-84.7%$918.80M$5.59B-2.381,117Analyst ForecastShort Interest ↑News CoverageCSTLCastle Biosciences2.8419 of 5 stars$28.65-0.8%$39.71+38.6%+40.2%$802.40M$311.88M144.35540Short Interest ↑GRALGrail0.5321 of 5 stars$22.77+2.8%$16.00-29.7%N/A$765.10M$117.67M0.001,360INNVInnovAge1.4494 of 5 stars$4.48+0.9%$6.50+45.1%-28.3%$606.84M$786.51M-37.002,350Analyst ForecastNews CoveragePositive NewsFLGTFulgent Genetics3.992 of 5 stars$19.65+0.4%$22.00+12.0%-31.0%$601.04M$277.76M-3.551,184AUNAAuna3.0186 of 5 stars$6.73+3.4%$13.40+99.1%N/A$497.47M$4.34B0.0014,958 Related Companies and Tools Related Companies AHCO Competitors CDNA Competitors PNTG Competitors AVAH Competitors AGL Competitors CSTL Competitors GRAL Competitors INNV Competitors FLGT Competitors AUNA Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:EHAB) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enhabit, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enhabit With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EHAB Stock Alerts